AAAAAA
Results:
1-21
|
Results: 21
Authors:
Posner, GH
Crawford, KR
Peleg, S
Welsh, JE
Romu, S
Gewirtz, DA
Gupta, MS
Dolan, P
Kensler, TW
Citation: Gh. Posner et al., A non-calcemic sulfone version of the vitamin D-3 analogue seocalcitol (EB1089): Chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin, BIO MED CH, 9(9), 2001, pp. 2365-2371
Authors:
White, MC
Burke, MD
Peleg, S
Brem, H
Posner, GH
Citation: Mc. White et al., Conformationally restricted hybrid analogues of the hormone 1 alpha,25-dihydroxyvitamin D-3: Design, synthesis, and biological evaluation, BIO MED CH, 9(7), 2001, pp. 1691-1699
Authors:
Siu-Caldera, ML
Rao, DS
Astecker, N
Weiskopf, A
Vouros, P
Konno, K
Fujishima, T
Takayama, H
Peleg, S
Reddy, GS
Citation: Ml. Siu-caldera et al., Tissue specific metabolism of 1 alpha,25-dihydroxy-20-epi-vitamin D-3 intonew metabolites with significant biological activity: Studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8), J CELL BIOC, 82(4), 2001, pp. 599-609
Authors:
Peleg, S
Ben-Ezra, M
Pritch, Y
Citation: S. Peleg et al., Omnistereo: Panoramic stereo imaging, IEEE PATT A, 23(3), 2001, pp. 279-290
Authors:
Liu, YY
Nguyen, C
Gradezi, SA
Schnirer, I
Peleg, S
Citation: Yy. Liu et al., Differential regulation of heterodimerization by 1 alpha,25-dihydroxyvitamin D-3 and its 20-epi analog, STEROIDS, 66(3-5), 2001, pp. 203-212
Authors:
Liu, YY
Nguyen, C
Gradezi, SA
Schnirer, I
Peleg, S
Citation: Yy. Liu et al., Differential regulation of heterodimerization by 1 alpha,25-dihydroxyvitamin D-3 and its 20-epi analog (vol 66, pg 203, 2001), STEROIDS, 66(10), 2001, pp. 793-793
Authors:
Gardezi, SA
Nguyen, C
Malloy, PJ
Posner, GH
Feldman, D
Peleg, S
Citation: Sa. Gardezi et al., A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D-3, J BIOL CHEM, 276(31), 2001, pp. 29148-29156
Authors:
Keren-Raifman, T
Bera, AK
Zveig, D
Peleg, S
Witherow, DS
Slepak, VZ
Dascal, N
Citation: T. Keren-raifman et al., Expression levels of RGS7 and RGS4 proteins determine the mode of regulation of the G protein-activated K+ channel and control regulation of RGS7 by G beta 5, FEBS LETTER, 492(1-2), 2001, pp. 20-28
Authors:
Yang, J
Fizazi, K
Peleg, S
Sikes, CR
Raymond, AK
Jamal, N
Hu, M
Olive, M
Martinez, LA
Wood, CG
Logothetis, CJ
Karsenty, G
Navone, NM
Citation: J. Yang et al., Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway, CANCER RES, 61(14), 2001, pp. 5652-5659
Authors:
Pritch, Y
Ben-Ezra, M
Peleg, S
Citation: Y. Pritch et al., Optics for omnistereo imaging, KLUW ENGN C, 628, 2001, pp. 447-467
Authors:
Peleg, S
Ben-Ezra, M
Pritch, Y
Citation: S. Peleg et al., Panoramic imaging with horizontal stereo, MG COMP SCI, 2001, pp. 143-160
Authors:
Peleg, S
Rousso, B
Rav-Acha, A
Zomet, A
Citation: S. Peleg et al., Mosaicing with strips on adaptive manifolds, MG COMP SCI, 2001, pp. 309-325
Authors:
Ben-Ezra, M
Peleg, S
Werman, M
Citation: M. Ben-ezra et al., Real-time motion analysis with linear programming, COMP VIS IM, 78(1), 2000, pp. 32-52
Authors:
Liu, YY
Nguyen, C
Peleg, S
Citation: Yy. Liu et al., Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor, MOL ENDOCR, 14(11), 2000, pp. 1776-1787
Authors:
Peleg, S
Rousso, B
Rav-Acha, A
Zomet, A
Citation: S. Peleg et al., Mosaicing on adaptive manifolds, IEEE PATT A, 22(10), 2000, pp. 1144-1154
Authors:
Lee, NE
Williard, PG
Brown, AJ
Campbell, MJ
Koeffler, HP
Peleg, S
Rao, DS
Reddy, GS
Citation: Ne. Lee et al., Synthesis and biological activities of the two C(23) epimers of 1 alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D-3: novel analogs of 1 alpha,23(S),25-trihydroxy-24-oxo-vitamin D-3, a natural metabolite of 1 alpha,25-dihydroxyvitamin D-3, STEROIDS, 65(5), 2000, pp. 252-265
Authors:
Singer-Lahat, D
Dascal, N
Mittelman, L
Peleg, S
Lotan, I
Citation: D. Singer-lahat et al., Imaging plasma membrane proteins in large membrane patches of Xenopus oocytes, PFLUG ARCH, 440(4), 2000, pp. 627-633
Authors:
Posner, GH
Crawford, K
Siu-Caldera, ML
Reddy, GS
Sarabia, SF
Feldman, D
van Etten, E
Mathieu, C
Gennaro, L
Vouros, P
Peleg, S
Dolan, PM
Kensler, TW
Citation: Gh. Posner et al., Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1 alpha,25-dihydroxyvitamin D-3: Synthesis and biological evaluation, J MED CHEM, 43(19), 2000, pp. 3581-3586
Authors:
Norman, AW
Manchand, PS
Uskokovic, MR
Okamura, WH
Takeuchi, JA
Bishop, JE
Hisatake, JI
Koeffler, HP
Peleg, S
Citation: Aw. Norman et al., Characterization of a novel analogue of 1 alpha,25(OH)(2)-vitamin D-3 withtwo side chains: Interaction with its nuclear receptor and cellular actions, J MED CHEM, 43(14), 2000, pp. 2719-2730
Authors:
Siu-Caldera, ML
Sekimoto, H
Peleg, S
Nguyen, C
Kissmeyer, AM
Binderup, L
Weiskopf, A
Vouros, P
Uskokovic, MR
Reddy, GS
Citation: Ml. Siu-caldera et al., Enhanced biological activity of 1 alpha,25-dihydroxy-20-epi-vitamin D-3, the C-20 epimer of 1 alpha,25-dihydroxyvitamin D-3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity, J STEROID B, 71(3-4), 1999, pp. 111-121
Authors:
Posner, GH
Wang, Q
Han, GH
Lee, JK
Crawford, K
Zand, S
Brem, H
Peleg, S
Dolan, P
Kensler, TW
Citation: Gh. Posner et al., Conceptually new sulfone analogues of the hormone 1 alpha,25-dihydroxyvitamin D-3: Synthesis and preliminary biological evaluation, J MED CHEM, 42(18), 1999, pp. 3425-3435
Risultati:
1-21
|